FRI0070 Angiotensin II type 2 receptor (AT2R) is overexpressed in rheumatoid arthritis and osteoarthritis synovium and increases steadily with inflammatory stimuli: a potential new target for pain and anti-inflammatory therapies. (15th June 2017)
- Record Type:
- Journal Article
- Title:
- FRI0070 Angiotensin II type 2 receptor (AT2R) is overexpressed in rheumatoid arthritis and osteoarthritis synovium and increases steadily with inflammatory stimuli: a potential new target for pain and anti-inflammatory therapies. (15th June 2017)
- Main Title:
- FRI0070 Angiotensin II type 2 receptor (AT2R) is overexpressed in rheumatoid arthritis and osteoarthritis synovium and increases steadily with inflammatory stimuli: a potential new target for pain and anti-inflammatory therapies
- Authors:
- Terenzi, R
Manetti, M
Rosa, I
Romano, E
Galluccio, F
Guiducci, S
Ibba-Manneschi, L
Matucci-Cerinic, M - Abstract:
- Abstract : Background: Despite increasing evidence suggesting that angiotensin II type 2 receptor (AT2R) antagonism might be a feasible strategy for the treatment of chronic inflammation and pain, no study has yet analyzed the synovial expression of AT2R. Objectives: To investigate the expression of AT2R in rheumatoid arthritis (RA) and osteoarthritis (OA) synovium and its possible modulation in fibroblast-like synoviocytes (FLS) by proinflammatory stimuli. Methods: The expression of AT2R in RA and OA synovium was investigated by immunohistochemistry. AT2R expression in synovial T cells, B cells, macrophages and FLS was assessed by double immunofluorescence. FLS were isolated from healthy (H), OA and RA synovium and treated with tumor necrosis factor (TNF)-α and interleukin (IL)-1β, alone or in combination. Immunocytochemistry and Western blotting were performed to study AT2R expression in cultured FLS. Results: RA synovium showed stronger AT2R immunostaining than OA synovium in the lining and sublining layers. In RA synovium, AT2R was strongly expressed in CD3+ T cells, CD20+ B cells, CD68+ macrophages and vimentin+ FLS. High levels of AT2R were found in OA-FLS and RA-FLS at baseline, while AT2R expression was negligible in basal H-FLS. AT2R expression was higher in RA-FLS than OA-FLS. Treatment with TNF-α and IL-1β was able to foster the expression of AT2R not only in OA-FLS and RA-FLS, but also in H-FLS. Conclusions: AT2R is strongly expressed in different cell types ofAbstract : Background: Despite increasing evidence suggesting that angiotensin II type 2 receptor (AT2R) antagonism might be a feasible strategy for the treatment of chronic inflammation and pain, no study has yet analyzed the synovial expression of AT2R. Objectives: To investigate the expression of AT2R in rheumatoid arthritis (RA) and osteoarthritis (OA) synovium and its possible modulation in fibroblast-like synoviocytes (FLS) by proinflammatory stimuli. Methods: The expression of AT2R in RA and OA synovium was investigated by immunohistochemistry. AT2R expression in synovial T cells, B cells, macrophages and FLS was assessed by double immunofluorescence. FLS were isolated from healthy (H), OA and RA synovium and treated with tumor necrosis factor (TNF)-α and interleukin (IL)-1β, alone or in combination. Immunocytochemistry and Western blotting were performed to study AT2R expression in cultured FLS. Results: RA synovium showed stronger AT2R immunostaining than OA synovium in the lining and sublining layers. In RA synovium, AT2R was strongly expressed in CD3+ T cells, CD20+ B cells, CD68+ macrophages and vimentin+ FLS. High levels of AT2R were found in OA-FLS and RA-FLS at baseline, while AT2R expression was negligible in basal H-FLS. AT2R expression was higher in RA-FLS than OA-FLS. Treatment with TNF-α and IL-1β was able to foster the expression of AT2R not only in OA-FLS and RA-FLS, but also in H-FLS. Conclusions: AT2R is strongly expressed in different cell types of the inflamed synovium and proinflammatory stimuli may foster the expression of AT2R in FLS. AT2R might represent a novel potential therapeutic target in chronic arthritides. Disclosure of Interest: None declared … (more)
- Is Part Of:
- Annals of the rheumatic diseases. Volume 76(2017)Supplement 2
- Journal:
- Annals of the rheumatic diseases
- Issue:
- Volume 76(2017)Supplement 2
- Issue Display:
- Volume 76, Issue 2 (2017)
- Year:
- 2017
- Volume:
- 76
- Issue:
- 2
- Issue Sort Value:
- 2017-0076-0002-0000
- Page Start:
- 504
- Page End:
- 504
- Publication Date:
- 2017-06-15
- Subjects:
- Rheumatism -- Periodicals
616.723005 - Journal URLs:
- http://ard.bmjjournals.com/ ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=149&action=archive ↗
http://www.bmj.com/archive ↗
http://gateway.ovid.com/server3/ovidweb.cgi?T=JS&MODE=ovid&D=ovft&PAGE=titles&SEARCH=annals+of+the+rheumatic+diseases.tj&NEWS=N ↗ - DOI:
- 10.1136/annrheumdis-2017-eular.1338 ↗
- Languages:
- English
- ISSNs:
- 0003-4967
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 18144.xml